 |
riluzole orally disolving tablet |
|---|---|
| Trade Name | |
| Orphan Indication | Amyotrophic lateral sclerosis |
| USA Market Approval | USA |
| USA Designation Date | 2016-11-30 00:00:00 |
| Sponsor | Biohaven Pharmaceutical Holding Company, Ltd;234 Church Street, Suite 304;New Haven, Connecticut, 06511 |
